| Financial Year |
March 31 2023 |
| Monetary Funds |
167,582,051.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
238,533,411.59 |
| Accounts Receivable |
679,739,235.64 |
| Advances to Suppliers |
15,748,229.59 |
| Other Receivables |
1,469,590,143.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
584,695,254.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
95,965,045.99 |
| Total Current Assets |
3,356,432,534.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
177,501,288.90 |
| Investment Properties |
-- |
| Fixed Assetes |
171,440,412.22 |
| Under-construction Projects |
2,475,735.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
78,788,765.39 |
| R&D expenses |
29,011,010.34 |
| Goodwill |
2,129,391,541.82 |
| Long-Term Deferred and Prepaid Expenses |
5,583,155.82 |
| Deferred Income Tax Assets |
14,421,086.69 |
| Other Non-Current Assets |
58,220,416.41 |
| Sub-Total of Non-Current Assets |
2,671,067,244.19 |
| Total Assets |
6,027,499,778.42 |
| Short-Term Loans |
547,895,603.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
249,175,223.38 |
| Accounts Payable |
131,517,687.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,817,350.35 |
| Taxes Payable |
13,784,187.24 |
| Interest Payable |
-- |
| Dividend Payable |
1,513,074.08 |
| Other payables |
40,003,980.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
416,853,034.39 |
| Other Current Liabilities |
16,053,090.09 |
| Sub-Total of Current Liabilities |
1,429,252,998.43 |
| Long-term Loans |
1,409,669,541.41 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
32,074,130.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,546,419.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,456,234,279.14 |
| Total Liabilities |
2,885,487,277.57 |
| Paid-In Capital(Or Share Stock) |
1,595,678,796.00 |
| Capital Surplus |
1,795,593,988.58 |
| Surplus Reserve |
94,202,207.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-368,642,449.94 |
| Minority Stockholder's Interest |
38,751,657.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,103,260,843.56 |
| Owner's Equity（Stockholder's Equity） |
3,142,012,500.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,027,499,778.42 |
